Pharming, a Dutch biotechnology firm, recently began clinical trials for alpha-glucosidase, a product designed to treat Pompe's disease, a metabolic disorder causing fatal degeneration of muscle.

ECONOMIST: Rare diseases: Safety in numbers | The